Discovery

Vanderbilt wins USD 1.77 million NIH grant to probe TBX4 pulmonary hypertension mechanisms

orglookupsummary note: The verified AllSci organization profile URL from orglookupsummary is...

NYU investigates long non-coding RNAs as drivers of stress susceptibility and resilience

New York University School of Medicine has received a USD 1.69 million NIH R56 award to investigate the role of long non-coding RNAs in stress...

Jinan University develops light-activated hydrogel system targeting lipid metabolism and postsurgical tumor recurrence

Researchers at Jinan University in Guangzhou, China have reported a thermotropic hydrogel tumor therapy platform that exploits the fatty acid-rich...

Scripps wins NCI renewal to study circadian control of HIF2α in kidney cancer

Scripps Research has received a USD 1.39 million NCI R01 renewal to investigate how circadian clock proteins regulate HIF2α activity in clear cell renal...

UBC researchers suggest semaglutide's skeletal effects reflect weight loss, not GLP-1 activity

Researchers at the University of British Columbia (UBC) in Vancouver, Canada report that semaglutide produces measurable reductions in bone mass and...

Scribe takes USD 25m in CIRM funding to push CRISPR CVD programs into clinic

Scribe Therapeutics has received more than USD 25 million from the California Institute for Regenerative Medicine (CIRM) to advance two preclinical...

Jun 18

Oligomerix picks up NIH grant to push oral tau inhibitor into clinic for Alzheimer's

Oligomerix, a clinical-stage biotechnology company based at the Albert Einstein College of Medicine in the Bronx, New York, has received a USD 1.9 million...

Michael J. Fox Foundation backs Neuron23's LRRK2 trial expansion into Israel

South San Francisco-based Neuron23 has received a USD 2.5 million grant from The Michael J. Fox Foundation for Parkinson's Research to expand its NEULARK...

NIDA renews support for Northeastern cannabinoid drug discovery program

Northeastern University has received a USD 1.43 million NIDA P01 program project renewal to advance structure-guided drug discovery targeting CB1 and CB2...

Rutgers researchers explore PARP1 inhibition as strategy against chemotherapy-related cognitive impairment

Rutgers Biomedical and Health Sciences has received a USD 1.78 million National Cancer Institute R01 award to identify biomarkers and evaluate therapeutic...

UCSF explores molecular drivers of pulmonary veno-occlusive disease

University of California, San Francisco has received a USD 1.63 million NIH R01 grant from the National Heart, Lung, and Blood Institute to investigate the...

Mayo Clinic expands multi-ethnic blood biomarker effort for Alzheimer's disease

Mayo Clinic Jacksonville has received a USD 8.16 million National Institute on Aging U19 renewal grant to advance blood-based biomarker discovery for...

Columbia investigates HPF1's role in PARP inhibitor bone marrow toxicity

Columbia University Health Sciences has received a USD 1.83 million NIH R01 grant from the National Cancer Institute to investigate how Histone PARylation...

Fred Hutch investigates how Par-4 eliminates dormant breast cancer cells

Fred Hutch Cancer Center has received a USD 1.8 million NCI R01 renewal to investigate how the tumor suppressor Par-4 regulates actomyosin contractility as...